A simplified, two-factor clinical prognostic scoring system for patients with newly diagnosed Hodgkins Lymphoma
Open Access
- 11 November 2024
- journal article
- letter
- Published by Springer Nature in Blood Cancer Journal
- Vol. 14 (1) , 1-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Simplified Risk Stratification Model for Patients With Waldenström MacroglobulinemiaJournal of Clinical Oncology, 2024
- Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma TrialJournal of Clinical Oncology, 2024
- Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s LymphomaNew England Journal of Medicine, 2022
- Medical imaging and nuclear medicine: a Lancet Oncology CommissionThe Lancet Oncology, 2021
- Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin Study Group trials HD16, HD17, and HD18Annals of Oncology, 2018
- Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s LymphomaNew England Journal of Medicine, 2016
- Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working GroupJournal of Clinical Oncology, 2015
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano ClassificationJournal of Clinical Oncology, 2014
- PROGNOSTIC FACTORS IN HODGKIN LYMPHOMAMediterranean Journal of Hematology and Infectious Diseases, 2014
- The role of cytokines in classical Hodgkin lymphomaBlood, 2002